These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11083654)

  • 1. Linezolid therapy of Staphylococcus aureus experimental osteomyelitis.
    Patel R; Piper KE; Rouse MS; Steckelberg JM
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3438-40. PubMed ID: 11083654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection.
    Baldoni D; Haschke M; Rajacic Z; Zimmerli W; Trampuz A
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1142-8. PubMed ID: 19075065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model.
    Yin LY; Calhoun JH; Thomas TS; Wirtz ED
    J Antimicrob Chemother; 2009 Feb; 63(2):357-60. PubMed ID: 19060292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
    Murillo O; Doménech A; Garcia A; Tubau F; Cabellos C; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4011-7. PubMed ID: 17015630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Dailey CF; Dileto-Fang CL; Buchanan LV; Oramas-Shirey MP; Batts DH; Ford CW; Gibson JK
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2304-8. PubMed ID: 11451689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis.
    Vergidis P; Rouse MS; Euba G; Karau MJ; Schmidt SM; Mandrekar JN; Steckelberg JM; Patel R
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1182-6. PubMed ID: 21189340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of linezolid plus rifampin in an experimental model of methicillin-susceptible Staphylococcus aureus endocarditis.
    Dailey CF; Pagano PJ; Buchanan LV; Paquette JA; Haas JV; Gibson JK
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2655-8. PubMed ID: 12878535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of post-traumatic hand Staphylococcus aureus osteomyelitis with oral linezolid.
    Pasticci MB; Altissimi M; Azzará A; Di Candilo F; Lapalorcia LM; Giustelli G; Pea F; Baldelli F
    J Chemother; 2006 Aug; 18(4):425-9. PubMed ID: 17024800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Linezolid in methicillin-resistant staphylococcus aureus infections].
    Pagani L; Viale P
    Unfallchirurg; 2002 Aug; 105(8):759-60; author reply 760. PubMed ID: 12243023
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus treated with a polylactide carrier releasing linezolid.
    Tsiolis P; Giamarellos-Bourboulis EJ; Mavrogenis AF; Savvidou O; Lallos SN; Frangia K; Lazarettos I; Nikolaou V; Efstathopoulos NE
    Surg Infect (Larchmt); 2011 Apr; 12(2):131-5. PubMed ID: 21348763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A delivery system of linezolid to enhance the MRSA osteomyelitis prognosis: in vivo experimental assessment.
    Gaudin A; Jacqueline C; Gautier H; Desessard C; Le Mabecque V; Miegeville AF; Potel G; Bouler JM; Weiss P; Caillon J; Amador G
    Eur J Clin Microbiol Infect Dis; 2013 Feb; 32(2):195-8. PubMed ID: 22923229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus bacteremias.
    Melzer M; Goldsmith D; Gransden W
    Clin Infect Dis; 2000 Jul; 31(1):208-9. PubMed ID: 10913433
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection.
    Yanagihara K; Kaneko Y; Sawai T; Miyazaki Y; Tsukamoto K; Hirakata Y; Tomono K; Kadota J; Tashiro T; Murata I; Kohno S
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3288-91. PubMed ID: 12234863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for a low linezolid trough plasma concentration in acute infections.
    Morata L; Cuesta M; Rojas JF; Rodriguez S; Brunet M; Casals G; Cobos N; Hernandez C; Martínez JA; Mensa J; Soriano A
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1913-7. PubMed ID: 23403416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model.
    Jacqueline C; Batard E; Perez L; Boutoille D; Hamel A; Caillon J; Kergueris MF; Potel G; Bugnon D
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3706-11. PubMed ID: 12435665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus infections.
    Johnson JR
    Clin Infect Dis; 2003 Jan; 36(2):236-7. PubMed ID: 12522761
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus.
    Jacqueline C; Navas D; Batard E; Miegeville AF; Le Mabecque V; Kergueris MF; Bugnon D; Potel G; Caillon J
    Antimicrob Agents Chemother; 2005 Jan; 49(1):45-51. PubMed ID: 15616274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis.
    Jacqueline C; Amador G; Caillon J; Le Mabecque V; Batard E; Miègeville AF; Biek D; Ge Y; Potel G; Hamel A
    J Antimicrob Chemother; 2010 Aug; 65(8):1749-52. PubMed ID: 20530506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid resistance in a clinical isolate of Staphylococcus aureus.
    Tsiodras S; Gold HS; Sakoulas G; Eliopoulos GM; Wennersten C; Venkataraman L; Moellering RC; Ferraro MJ
    Lancet; 2001 Jul; 358(9277):207-8. PubMed ID: 11476839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on: linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
    De Beeck VO; Dhif N; Philipp J; De Bels D
    J Antimicrob Chemother; 2006 Mar; 57(3):577. PubMed ID: 16431858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.